Joseph S. Payne

Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $45 million SEC-registered common stock and pre-funded warrants offering…

Davis Polk advised the joint book-running managers in connection with an offering by Beazer Homes USA, Inc. of $350 million aggregate principal amount of its 7.250% notes due 2029. Davis…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of €600 million of 0.250% notes due 2024, €500 million of 0.625% notes due 2027 and €500…

Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $19 billion in aggregate principal amount of senior notes by Bristol-Myers…

Davis Polk advised the representative of the several underwriters in connection with the $81.9 million initial public offering of 6,300,000 shares of Class A common stock of Mercantil Bank…

Davis Polk advised the representatives of the underwriters in connection with the $50 million initial public offering of 6,250,000 ordinary shares of Gamida Cell Ltd. The ordinary…

Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with separate private exchange offers for its existing 12% senior secured notes due 2020 held by certain holders for new…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by KKR Group Finance Co. IV LLC, a wholly owned finance subsidiary of KKR & Co. L.P., of …

Davis Polk advised the joint book-running managers and as representatives of the several underwriters in connection with a public offering by PPG Industries, Inc. of $300 million aggregate…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Celgene Corporation of $500 million aggregate…